Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 333-262600

Pioneer Green Farms, Inc.

(Exact name of registrant as specified in its charter)

Florida		83-3417168
(State or other jurisdiction of		(I.R.S. employer
incorporation or formation)		identification number)

1301 10^th Avenue, East, Suite G

Palmetto, FL 34221

Tel: (727) 304-8003

(Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices)

Securities registered pursuant to Section l 2(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

As of November 18, 2024, there were 28,911,300 shares of the issuer's common stock, $0.00001 par value, outstanding.

Pioneer Green Farms, Inc.

Table of Contents

		Page
PART I - FINANCIAL INFORMATION:
Item 1. Financial Statements		4
Unaudited Financial Statements
Unaudited Balance Sheets		4
Unaudited Statements of Operations		5
Unaudited Statement of Stockholders' Equity (Deficit)		6
Unaudited Statements of Cash Flows		7
Notes to Unaudited Financial Statements		8
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations		14
Item 3. Quantitative and Qualitative Disclosures about Market Risk		19
Item 4. Controls and Procedures		19
PART II - OTHER INFORMATION:
Item 1. Legal Proceedings		20
Item 1A. Risk Factors		20
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		20
Item 3. Defaults Upon Senior Securities		20
Item 4. Mine Safety Disclosures		20
Item 5. Other Information		20
Item 6. Exhibits		21
Signatures		22

NOTE ON FORWARD-LOOKING STATEMENTS

This Form 10-Q contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. For a more detailed listing of some of the risks and uncertainties facing the Company, please see our Registration Statement on Form S-1, as amended, filed with the Securities and Exchange Commission ("SEC") on May 27, 2022.

All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise after the date of this filing, except where applicable law requires us to update these statements. Market data used throughout this filing is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this filing may not occur and actual results could differ materially from those anticipated or implied in the forward- looking statements. In addition, in this filing, we use words such as "anticipate," "believe," "plan," "expect," "future," "intend," and similar expressions to identify forward-looking statements.

Should one or more of these risks or uncertainties occur, or should underlying assumptions prove to be incorrect, actual results may vary materially and adversely from those anticipated, believed, estimated or otherwise indicated. Consequently, all of the forward‐ looking statements made in this Quarterly Report are qualified by these cautionary statements and accordingly there can be no assurances made with respect to the actual results or developments. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

Unless expressly indicated or the context requires otherwise, the terms "Company," "we," "us," and "our" in this document refer to Pioneer Green Farms, Inc., a Florida corporation.

Item 1. Financial Statements.

Pioneer Green Farms Inc.
Balance Sheets
As of September 30, 2024, and December 31, 2023
		September 31, 2024 (Unaudited)			December 31, 2023 (Audited)
Assets
Current assets
Cash and cash equivalents		$	6,026			$	627
Inventory			31,515				15,000
Due from affiliate			4,390				5,400
Other current assets			23,450				4,500
			65,381				25,527
Property and equipment, net			378,474				380,655
Lease right of use, net			175,512				186,424
Total assets		$	619,367			$	592,606
Liabilities and Shareholders' Deficit
Current liabilities
Accounts payable		$	30,887			$	78,825
Related party loans			566,360				600,292
Land purchase notes payable			310,500				310,500
Short-term portion of leases liability			1,363				6,143
			909,110				995,760
Lease liability			207,962				209,017
Total liabilities			1,117,072				1,204,777
Commitments and Contingencies (Note 7)
Shareholders' Deficit
Common stock, 100,000,000 shares authorized, $0.00001 par value, 28,779,300 and 23,506,300 issued and outstanding at September 30, 2024 and December 31, 2023, respectively			289				235
Additional paid in capital			3,998,485				901,984
Subscriptions for stock to be issued			10,000				109,100
Accumulated deficit			(4,506,479	)			(1,623,490	)
Total shareholders' deficit			(497,705	)			(612,171	)
Total liabilities and shareholders' deficit		$	619,367			$	592,606

The accompanying notes are an integral part of these unaudited statements.

Pioneer Green Farms Inc.
Statements of Operations
Three and Nine Months Ended September 30, 2024 and 2023 (Unaudited)
		Three Months Ended September 30, 2024			Three Months Ended September 30, 2023			Nine Months Ended September 30, 2024			Nine Months Ended September 30, 2023
Revenues		$	43			$	-			$	54,267			$	9,295
Cost of sales			13				-				25,347				5,450
Gross profit			30				-				28,920				3,845
General and administrative expenses
General and administration			78,865				37,692				539,766				118,278
Professional fees			7,356				42,000				374,097				89,245
Research and development			-				-				21,819				-
Sales and marketing			97				-				15,697				-
Labor and management			12,902				22,300				12,902				109,314
Depreciation and amortization			2,449				2,465				7,222				7,263
			101,669				104,457				971,503				324,100
Operating loss			(101,639	)			(104,457	)			(942,583	)			(320,255	)
Interest expense			14,235				641				51,140				12,295
Other (income) expense			1,511,496				(11	)			1,889,266				-
Loss before income taxes			(1,627,370	)			(105,087	)			(2,882,989	)			(332,550	)
Less Income tax expense			-				-				-				-
Net loss		$	(1,627,370	)		$	(105,087	)		$	(2,882,989	)		$	(332,550	)
Weighted average shares			27,925,454				23,506,300				26,665,800				23,428,474
Earnings per share - basic and diluted		$	(0.06	)		$	(0.01	)		$	(0.11	)		$	(0.01	)

The accompanying notes are an integral part of these unaudited statements.

Pioneer Green Farms Inc.
Statement of Changes in Members' and Shareholders' Deficit
For the Nine Months Ended September 30, 2023 and 2024
Unaudited

		Number of shares			Common stock			Additional Paid in Capital			Stock to be Issued			Accumulated deficit			Total
Balance, December 31, 2022			23,120,000			$	231			$	845,538			$	43,650			$	(1,220,120	)		$	(330,701	)
Stock issued for cash			210,500				2				12,798				-				-				12,800
Stock issued from registration statement			175,800				2				43,648				(43,650	)			-				-
Net loss							-				-								(95,478	)			(95,478	)
Balance, March 31, 2023			23,506,300				235				901,984				-				(1,315,598	)			(413,379	)
Net loss							-				-				-				(131,965	)			(131,965	)
Balance, June 30, 2023			23,506,300			$	235			$	901,984			$	-			$	(1,447,563	)		$	(545,344	)
Cash collected on registration statement			-				-				-				10,100				-				10,100
Net loss							-				-				-				(105,087	)			(105,087	)
Balance, September 30, 2023			23,506,300				235				901,984				10,100				(1,552,650	)			(640,331	)
Balance, December 31, 2023			23,506,300			$	235			$	901,984			$	109,100			$	(1,623,490	)		$	(612,171	)
Stock issued for services			1,550,000				16				726,934				-				-				726,950
Stock issued for debt			400,000				4				187,596								-				187,600
Stock issued from registration statement							-				-				27,500				-				27,500
Net loss							-				-				-				(949,305	)			(949,305	)
Balance, March 31, 2024			25,456,300				255				1,816,514				136,600				(2,572,795	)			(619,426	)
Stock issued for cash			150,000				2				14,998				-				-				15,000
Stock issued for services			31,000				0				14,539				-				-				14,539
Stock issued for debt			630,000				6				295,464				-				-				295,470
Imputed interest contribution							-				34,100				-				-				34,100
Stock issued from registration statement			112,000				1				15,999				(26,600	)			-				(10,600	)
Net loss							-				-				-				(306,314	)			(306,314	)
Balance, June 30, 2024			26,379,300			$	264			$	2,191,614			$	110,000			$	(2,879,109	)		$	(577,231	)
Stock issued for services			100,000				1				46,899				-				-				46,900
Stock issued for debt			1,400,000				14				820,386				-				-				820,400
Imputed interest contribution							-				13,800				-								13,800
Warrant Issuance Expense			-				-				825,796				-				-				825,796
Stock issued from registration statement			1,000,000				10				99,990				(100,000	)			-				-
Net loss							-				-				-				(1,627,370	)			(1,627,370	)
Balance, September 30, 2024			28,779,300			$	289			$	3,998,485			$	10,000			$	(4,506,479	)		$	(497,705	)

The accompanying notes are an integral part of these unaudited statements.

Pioneer Green Farms Inc.
Statement of Cash Flows
Nine Months Ended September 30, 2024 and 2023
(Unaudited)
		Nine Months Ended September 30, 2024			Nine Months Ended September 30, 2023
Cash used in Operating activities
Net loss		$	(2,882,989	)		$	(332,530	)
Items not affecting cash:
Depreciation & amortization			7,222				7,263
Debt discount amortization			-				10,000
Imputed interest contribution			47,900				-
Derivative loss			825,796				-
Loss on settlement and disposal			1,063,470				-
Shares issued for services			788,389				-
Changes in non-cash working capital:
Inventory			(16,515	)			5,908
Due from affiliates			1,010				-
Other current assets			(18,950	)			22,493
Right of use asset			10,912				(20,897	)
Accounts payable			(13,938	)			15,220
Other current liabilities			-				(74,159	)
Lease liability			(5,835	)			6,541
Net cash flows from operating activities			(193,528	)			(360,161	)
Investing activities
Purchase of Assets			(5,041	)			(3,650	)
Net cash flows from investing activity			(5,041	)			(3,650	)
Financing activities
Repayments on long term debt			-				(1,000	)
Advances from (repayments to) related parties, net			172,068				343,977
Subscriptions for stock to be issued			(64,050	)			10,100
Proceeds from sale of stock			95,950				12,800
Net cash flows from financing activities			203,968				365,877
Increase (decrease) in cash during the year			5,399				2,066
Cash, beginning of the period			627				11,532
Cash, end of the period		$	6,026			$	13,598
Supplemental disclosures
Cash paid for income taxes		$	-			$	-
Cash paid for interest		$	-			$	-
Stock issued from subscriptions		$	100,000			$	-
Stock issued for debt		$	240,000			$	-

The accompanying notes are an integral part of these unaudited statements.

Pioneer Green Farms Inc.

Notes to the Financial Statements

September 30, 2024

Unaudited

NOTE 1 -ORGANIZATION AND NATURE OF BUSINESS

Pioneer Green Farms LLC was established in the State of Florida on January 25, 2019, to start business operations in the agricultural segment of growing hemp products. On May 10, 2021, the Company was converted to a Florida corporation and changed its name to Pioneer Green Farms, Inc. (the "Company").

NOTE 2 -SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The interim financial statements of the Company are unaudited. These Financial Statements include all adjustments, consisting only of normal recurring adjustments, considered necessary by management to fairly state the Company's results of operations, financial position, and cash flows. The results reported in these Financial Statements are not necessarily indicative of the results that may be expected for the entire year. The 2023 year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America (GAAP).

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.

Accounts Receivable

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience. No allowance for doubtful accounts was recorded for the periods ended September 30, 2024, and December 31, 2023.

Inventories

Inventories are stated at the lower of cost or market, using the FIFO method. The Company also determines a reserve for excess and obsolete inventory based on historical usage and projecting the year in which inventory will be consumed into a finished product. The valuation of inventories requires management to make significant assumptions, including the assessment of market value by inventory category considering historical usage, future usage and market demand for their products, and qualitative judgments related to discontinued, slow moving and obsolete inventories.

Seeds purchased and not planted at period end are recorded as inventory at the cost of the seeds. CBD flower in the field are not valued separately. The costs to plant seeds are expenses as incurred. Only after harvesting, drying, and extracting the oil is an inventory recorded for the cost of extracting and packaging the oil.

Property and equipment

Property and equipment are carried at cost less accumulated depreciation. Depreciation is provided over the assets' estimated useful lives, using the straight-line method.

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the statement of income. The cost of maintenance and repairs is charged to the statement of income as incurred, whereas significant renewals and betterments are capitalized.

Depreciation, Amortization, and Capitalization

The Company records depreciation and amortization when appropriate using the straight-line balance method over the estimated useful life of the assets. The Company estimates that the useful life of its buildings and improvements is 15 years and of its machinery and equipment is three to seven years. Expenditures for maintenance and repairs are charged to expense as incurred. Additions, major renewals and replacements that increase the property's useful life are capitalized. Property sold or retired, together with the related accumulated depreciation is removed from the appropriate accounts and the resultant gain or loss is included in net income.

Impairment of Long-lived Assets

Long-lived assets such as property, equipment and identifiable intangibles are reviewed for impairment at least annually or whenever facts and circumstances indicate that the carrying value may not be recoverable. When required, impairment losses on assets to be held and used are recognized based on the fair value of the asset. The fair value is determined based on estimates of future cash flows, market value of similar assets, if available, or independent appraisals, if required. If the carrying amount of the long-lived asset is not recoverable, an impairment loss is recognized for the difference between the carrying amount and fair value of the asset. The Company did not recognize an impairment loss during the Nine months ended September 30, 2024.

Fair Value of Financial Instruments

Accounting Standards Codification ("ASC") 820 Fair Value Measurements and Disclosures establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.

These tiers include:

Level 1:	defined as observable inputs such as quoted prices in active markets;
Level 2:	defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
Level 3:	defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

The carrying value of the Company's cash, other current assets, accounts payable, accrued expenses and loan from shareholders approximates its fair value due to their short-term maturity.

Income Taxes

The Company accounts for its income taxes in accordance with ASC 740 Income Taxes, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases and tax credits and carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Update (ASU) 2014-09, Revenue from contracts with customers (Topic 606). Revenue is recognized when a customer obtains control of promised goods of services. The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.

The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled in exchange for the goods or services it transfers to the customer. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company's performance obligations are transferred to customers at a point in time, typically upon delivery.

A small portion of the Company's revenue comes from on-line purchases of retail inventory, acquired from vendors for resale. These sales are recorded when the order has been packaged and mailed and the online payment has been collected by the Company.

The larger portion of current revenues are from wholesale products delivered to customers or vendors at an agreed upon price. This revenue is recognized when the products are delivered and the consideration is received.

Cost of Goods Sold

Cost of goods sold includes direct costs of selling items, direct labor cost, processing, and packaging costs.

Leases

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right of use ("ROU") assets, and operating lease liabilities in our balance sheets. Finance leases are included in property and equipment, other current liabilities, and other long-term liabilities in the balance sheets.

ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the leases do not provide an implicit rate, the Company generally uses the incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease.

Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Recent Accounting Pronouncements

There have been no other recent accounting pronouncements or changes in accounting pronouncements during the period ended September 30, 2024, that are of significance or potential significance to the Company.

Subsequent Events

In accordance with SFAS 165 (ASC 855), Subsequent Events the Company has analyzed its operations subsequent to September 30, 2024, to the date these financial statements were issued, and has determined that it does not have any other material subsequent events to disclose in these financial statements.

NOTE 3 -GOING CONCERN

The accompanying financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. However, the Company has minimal revenue and accumulated losses of $4,506,479 as of September 30, 2024. The Company has not completed its efforts to establish a stabilized source of revenue sufficient to cover operating costs over an extended period of time. Therefore, there is substantial doubt about the Company's ability to continue as a going concern.

Management anticipates that the Company will be dependent, in the near future, on additional investment capital to fund operating expenses. The Company intends to position itself so that it will be able to raise additional funds through the capital markets. In light of management's efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern.

NOTE 4 -INVENTORY

The following is a summary of inventories held:

		September 30, 2024			December 31, 2023
CDB oil		$	3,025			$	15,000
Seed Inventory			-				-
Retail health products			28,490				-
		$	31,515			$	15,000

NOTE 5 - PROPERTY AND EQUIPMENT

The following is a summary of property and equipment and accumulated depreciation:

		September 30, 2024			December 31, 2023
Greenhouses and outbuildings		$	47,706			$	47,706
Leasehold improvements			4,465				-
Land - Myakka farm			319,977				319,401
Machinery and equipment			36,382				36,382
			408,530				403,489
Accumulated depreciation			30,056				22,834
		$	378,474			$	380,655

Depreciation expenses for the three and nine months ended September 30, 2024, and 2023, were $2,449, and $2,412, and $7,222 and $7,263, respectively.

NOTE 6 -LAND PURCHASE NOTES PAYABLE

During December 2021 and January 2022, the Company collected $360,000 from 12 shareholders to purchase a second farm in Florida. The purchase closed in January 2022 and each investor received a promissory note for $30,000 and 100,000 shares of stock. The notes were payable within one year and the Company recorded $120,000 of prepaid interest on the issuance of the stock, which has been fully recognized as of September 30, 2024. Repayments of $0 and $1,000 occurred during the nine months ended September 30, 2024, and 2023, respectively. All outstanding notes have been negotiated to be due on demand.

NOTE 7 -COMMITMENTS AND CONTINGENCIES

The Company elected to adopt the policy not to apply the recognition provisions to short term leases, therefore, lease payments under short term leases will be recognized on a straight-line basis over the lease term.

As of July 1, 2020, the Company holds a 25-year lease to a 5-acre orange grove and out-buildings. The minimum rent for the property is $1,000 per month. The land lease increases by 3% each year on July 1.

The land lease has been capitalized, on July 1, 2020, as a right of use asset with an equal right of use liability using a discount rate of 6%. The initial present value of the right-of-use asset and liability was calculated to be $211,460. The Company determined this lease to be an operating lease since the land never transfers to the lessee. The asset value will be reduced on a straight-line basis over the 25-year term. The liability will be increased or reduced by payments by the Company which are below or more than the imputed interest on the outstanding lease liability.

On August 1, 2023, the Company acquired the remaining portion of an operating lease for office space in Palmetto from a related party. This lease has 10 months left on the original term of 36 months. The Company recorded a carry-over right-to-use asset $9,137 and a carry-over lease liability of $10,156 based on the original terms using a discount rate of 6%. The Company determined this lease to be an operating lease since the office space never transfers to the lessee. The asset value will be reduced on a straight-line basis over the remaining 10-month term. The liability will be increased or reduced by payments by the Company which are below or more than the imputed interest on the outstanding lease liability. This lease expired in May 2024. The company made additional monthly payment to close out the lease.

The Company has a cost sharing agreement with a related party to subsidize rent in the Bradenton area on a month-to-month basis. Total rent payments under this arrangement were $18,924 and $12,600 for the nine months ended September 30, 2024, and 2023, respectively.

On July 1, 2024, the Company entered into a six-month lease agreement for indoor growing space in Palmetto Florida. Consideration given was the promise of 100,000 shares of common stock at the market price $0.469. At September 30, 2024, half the shares, 50,000 at $0.469 or $23,450, are listed as prepaid rent. Half the shares were expensed at $0.469 per share or $23,450 as of July 1, 2024.

The following table provides disclosure on the leases as of September 30, 2024:

Description		Right of use Asset			Lease Liability			Future Minimum Payments			Imputed Interest			Current portion Lease Liability
Lease for Farm		$	175,512			$	209,325			$	383,932			$	174,607			$	1,363
Lease for Office			-				-				-
New grow space			-				-				-				-				-
Totals		$	175,512			$	209,325			$	383,932			$	174,607			$	1,363

		Three Months Ended			Nine Months ended			Annual
		September 30, 2023			September 30, 2023			September 30, 2023			September 30, 2023			Straight-line
		Recorded Lease Expense			Cash Paid on Lease Liability			Recorded Lease Expense			Cash Paid on Lease Liability			Lease expense
Lease for Farm		$	4,375			$	3,000			$	13,125			$	9,000			$	17,500
Lease for Office			1,469				-				8,602				5,215				4,989
Cost Sharing Month to Month			8,524				-				18,925				-				-
New grow space			23,450				-				23,450				-				93,800
Totals		$	37,818			$	3,000			$	64,102			$	14,215			$	116,289

Future minimum lease payments		Farm lease			Totals
2024			3,377				3,377
2025			13,709				13,709
2026			14,120				14,120
2027			15,773				15,773
2028			14,980				14,980
There after			321,973				321,973
Total future minimum lease payments		$	383,932			$	383,932
Less imputed interest							(174,607	)
							209,325
Less current portion							(1,363	)
Total operating lease liability						$	207,962

NOTE 8 -RELATED PARTY TRANSACTIONS

At September 30, 2024 and December 31, 2023 the Company owed $566,360 and $600,292 to related parties, including companies controlled by the CEO.. These amounts are non-interest bearing and due upon demand. The Company is imputing interest at 11% per annum during 2024.

NOTE 9 -SHAREHOLDERS'AND MEMBERS'EQUITY/DEFICIT

The Company is authorized to issue one hundred million (100,000,000) shares of common stock at $0.00001 per share. As of September 30, 2024, there were 28,779,300 shares issued and outstanding.

During the 1^st quarter of 2024, the Company issued 1,550,000 shares of common stock for $726,950 in services and 400,000 shares of common stock to vendors for $40,000 in accounts payable and a settlement loss of $147,600.

During the 2^nd quarter of 2024, the Company issued 150,000 shares of common stock for $15,000 cash, 31,000 shares of common stock for $14,539 in services, and 630,000 shares of common stock a $60,000 payment on a shareholder loan and a settlement loss of $235,470.

During the 3rd quarter of 2024, the Company issued 1,400,000 shares of common stock for $140,000 in shareholder loans and a loss on settlement of $680,400 and 1,000,000 shares of common stock for $100,000 of a subscription payable.

As of September 30, 2024, the Company has agreed to issue an additional 100,000 shares of common stock for $25,000 in prepaid rent and 100,000 shares for $10,000 in stock subscriptions.

NOTE 10 -INCOME TAXES

The Company elected to be taxed as a corporation and adopted the provisions of uncertain tax positions as addressed in ASC 740-10-65-1. As a result of the implementation of ASC 740-10-65-1, the Company recognized no increase in the liability for unrecognized tax benefits.

The Company has no tax position on September 30, 2024 or December 31, 2023 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company does not recognize interest accrued related to unrecognized tax benefits in interest expenses and penalties in operating expenses. No such interest or penalties were recognized during the period presented. The Company had no accruals for interest and penalties on September 30, 2024, or December 31, 2023. The Company's utilization of any net operating loss carry forward may be unlikely as a result of its intended activities.

The components of the Company's deferred tax asset and reconciliation of income taxes computed at the new federal and state statutory rate of 25.3% to the income tax amount recorded as of September 30, 2024, and December 31, 2023, are as follows:

		September 30, 2024			December 31, 2023
Accumulated loss		$	4,506,479			$	1,623,490
Book tax differences - stock-based comp			(2,840,855	)			(113,500	)
Net operating loss and carryforwards		$	1,665,624			$	1,509,990
Effective tax rate			25.3	%			25.3	%
Deferred tax asset, rounded			421,000				382,000
Less: Valuation allowance, rounded			(421,000	)			(382,000	)
Net deferred asset		$	-			$	-

NOTE 11 -SUBSEQUENT EVENTS

In October the Company issued 32,000 shares of common stock at par to a shareholder to correct a previous shortage.

In October, the Company agreed to convert $40,000 of shareholder debt to 160,000 common shares at $0.25 per share.

Item 2. Management's Discussion and Analysis.

The following Management's Discussion and Analysis of Financial Condition and Plan of Operations ("MD&A") is intended to help you understand our historical results of operations during the periods presented and our financial condition. This MD&A should be read in conjunction with our consolidated financial statements and the accompanying notes to consolidated financial statements and contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements. All forward-looking statements speak only as of the date on which they are made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they are made.

Basis of Presentation

The financial statements are prepared in conformity with generally accepted accounting principles in the United States of America ("U.S. GAAP").

Forward-Looking Statements

Some of the statements under "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in this Form 10-Q constitute forward-looking statements. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar matters that are not historical facts. In some cases, you can identify forward-looking statements by terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "should," and "would" or the negatives of these terms or other comparable terminology.

You should not place undue reliance on forward-looking statements. The cautionary statements set forth in this Form 10-Q identify important factors which you should consider in evaluating our forward-looking statements. These factors include, among other things:

●

The unprecedented impact of COVID-19 pandemic on our business, customers, employees, consultants, service providers, stockholders, investors and other stakeholders;

●

The speculative nature of the business we intend to develop;

●

Our reliance on suppliers and customers;

●

Our dependence upon external sources for the financing of our operations, particularly given that there are concerns about our ability to continue as a "going concern;"

●

Our ability to effectively execute our business plan;

●

Our ability to manage our expansion, growth and operating expenses;

●

Our ability to finance our businesses;

●

Our ability to promote our businesses;

●

Our ability to compete and succeed in highly competitive and evolving businesses;

●

Our ability to respond and adapt to changes in technology and customer behavior; and

●

Our ability to protect our intellectual property and to develop, maintain and enhance strong brands.

Although the forward-looking statements in this Form 10-Q are based on our beliefs, assumptions and expectations, taking into account all information currently available to us, we cannot guarantee future transactions, results, performance, achievements or outcomes. No assurance can be made to any investor by anyone that the expectations reflected in our forward-looking statements will be attained, or that deviations from them will not be material and adverse. We undertake no obligation, other than as maybe be required by law, to update this filing or otherwise make public statements updating our forward-looking statements.

Pioneer Greens Farms, Inc., (the "Company") was originally incorporated in Florida in January 2019. In 2019, the Company entered a joint-venture with Colorado- based Sugar Magnolia Hemp Farms LLC to cultivate hemp in the State of Colorado.

Due to the Company being based in Florida, it decided to apply for a hemp cultivation license in the State of Florida when the State of Florida legalized hemp production in July 2019. The climate in Florida enables the farms to grow three to four crops per year with much lower overhead as opposed to Colorado where only one crop can be grown annually at higher operational costs in an extremely competitive Colorado marketplace. Pioneer Green Farms entered a 25-year lease of 5 acres from Drymon's Citrus Nursery ("Drymon's"). Drymon's has been involved in citrus farming in Florida for many decades and has met all the State's guidelines for licensed applicants. Pioneer owns the farming infrastructure which is expansive and controls the revenues from the flower and oil extracts.

In April 2020, Drymon's was granted a hemp cultivation license by the Plant Division of the Florida Department of Agriculture and Consumer Services. The Company uses and controls the Drymon hemp cultivation license, as part of its lease agreement with Drymon. Pioneer was able to build, construct and outfit 4 - 30 ft x 100 ft greenhouses on Drymon's farm with water, lighting, and all equipment and specifications to ensure optimal uniform growing conditions and crop consistency approved by State regulations.

In January 2022, the Company completed the purchase of over five (5) acres of farmland in Myakka City, Manatee County, Florida. The Company intends to expand its operations by building at least six (6) more greenhouses and planting over eight thousand (8,000) outdoor hemp plants.

In November 2023, the Company launched two new products, Ink Bomb Tattoo Healing Spray and Healing Wash, and Big Banana Organic Libido Enhancer for His and Hers. The Company expects to benefit from this growing market and is optimistic that these products will generate a new revenue stream. These products will be marketed and sold directly by the Company, and through affiliate sales partner programs.

Impact of the Novel Coronavirus (COVID-19) and other Macroeconomic Factors on the Company's Business Operations

The global outbreak of the novel coronavirus (COVID-19) has led to severe disruptions in general economic activities worldwide, as businesses and governments have taken broad actions to mitigate this public health crisis. In light of the uncertain and continually evolving situation relating to the spread of COVID-19, this pandemic could pose a risk to the Company. The extent to which the coronavirus may impact the Company's business operations will depend on future developments, which are highly uncertain and cannot be predicted at this time. The Company intends to continue to monitor the situation and may adjust its current business plans as more information and guidance become available.

There is also significant uncertainty as to the effect that the coronavirus may have on the amount and type of financing available to the Company in the future.

Macroeconomic factors such as inflation, rising interest rates, governmental responses there to and possible recession caused thereby also add significant uncertainty to our operations and possible effects to the amount and type of financing available to the Company in the future.

Since our inception, we devoted substantially all of our efforts and funding to planting and harvesting hemp for extraction and raising capital. We have not yet generated revenues from our planned operations. However, in November 2023 the Company launched two new products, Ink Bomb Tattoo Healing Spray and Healing Wash, and Big Banana Organic Libido Enhancer for His and Hers, which the Company expects will continue to generate revenue. The Company also sells products through its website and retail store.

Results of Operations

Results of Operations during the three months ended September 30, 2024, as compared to the three months ended September 30, 2023.

For the three months ended September 30, 2024, we generated revenues of $43 compared to $0 for the three months ended September 30, 2023. Our Gross Profit from the sale of all products for the three months ended September 30, 2024, and three months ended September 30, 2023, was $30 and $0 respectively.

Our Net Loss for the three months ended September 30, 2024, and September 30, 2023, was ($1,627,370) and ($135,810) respectively, an increase of (1,098%). Our net loss increased primarily due to a charge for settlement of debt, derivative liability and increases in general and administrative expenses.. General administration costs increased by $41,406 due to increases in rents and interest for the quarter, in the three months ended September 30, 2024, we recognized a $685,700 loss on settlement of debt, the derivative loss was $825,796.

Results of Operations during the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023.

For the nine months ended September 30, 2024, we generated revenues of $54,267 compared to $9,295 for the nine months ended September 30, 2023. Our Gross Profit from the sale of all products for the nine months ended September 30, 2024, and nine months ended September 30, 2023, was $28,890 and $3,845 respectively.

Our sales in 2024, consisted of $2,427 of retail products with an average cost of 30% and $51,865 of wholesale products less $25 fee, which were acquired at fire sale prices or grown for further processing and held at $0 cost. Sales in 2023 of $9,295 were mostly wholesale CDB oil which was purchased at a much higher cost.

Our Net Loss for the nine months ended September 30, 2024, and September 30, 2023, was ($2,882,989) and ($332,550) respectively, an increase of (767%). Our net loss increased primarily due increases in general and administrative expenses, and professional fees for services relating to our public reporting compliance and annual audit and quarterly SEC filings and because for the nine months ended September 30, 2024, we recognized a $1,063,470 loss on settlement of debt and $825,796 in derivative loss. General administration costs increased by $421,488 due to increases in operational and consulting costs, professional fees increased by $284,852 due to our public reporting compliance and annual audit and quarterly SEC filings.

Liquidity and Capital Resources

As of September 30, 2024, we had $619,367 in total assets including cash and cash equivalents of $ 6,026, as compared to $592,606 in total assets including cash and cash equivalents of $627 as of December 31, 2023. The increase in total assets is primarily attributable to the increase in inventory and cash and cash equivalents.

As of September 30, 2024, we had total liabilities of $1,942,868 including accounts payable of $30,887, related party loans of $566,360, notes payable of $310,500, derivative liability of $825,796 and lease liabilities of $ 207,962 as compared to total liabilities of $1,204,777 including accounts payable of $78,825, related party loans of $600,292, notes payable of $310,500, and lease liabilities of $209,017 as of September 30, 2023. The decrease in total liabilities was mainly due to the increase in related party loans and the decrease in accounts payable.

Cash Flow from Operating Activities

Net cash used in operations for the nine months ended September 30, 2024, was ($193,528) as compared to ($360,161) for the nine months ended September 30, 2023.

Cash Flow from Investing Activities

Net cash used in investing activities for the nine months ended September 30, 2024, was ($5,041) as compared to ($3,650) for the nine months ended September 30, 2023.

Cash Flow from Financing Activities

Net cash provided by financing activities for the nine months ended September 30, 2024, was $203,968 as compared to $365,877 for the nine months ended September 30, 2023. Advances from related party debt were received in the nine months ended September 30, 2024.

There are no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues, expenses, results of operations, liquidity, capital expenditures or capital resources.

The Company has extended the term for the repayment of the Notes until February 2025, when it expects to have income from product sales, or raising funds from investors.

Critical Accounting Policies and Estimates

This discussion and analysis of our financial condition and results of operations are based on our financial statements that have been prepared under accounting principle generally accepted in the United States of America. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

A summary of significant accounting policies is included in Note 2 to the consolidated financial statements included in this filing. Of these policies, we believe that the following items are the most critical in preparing our financial statements.

USE OF ESTIMATES:

Management uses estimates and assumptions in preparing these financial statements in accordance with U.S. generally accepted accounting principles. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses.

REVENUE RECOGNITION:

Revenue from sale of goods is measured at fair value of the consideration received or receivable and is recognized in the statement of comprehensive income of the Company when significant risks and rewards of the ownership of the goods have been transferred to the buyers.

ACCOUNTS RECEIVABLE:

Accounts Receivable (AR) is the payment which the Company will receive from its customers who have purchased its goods & services in the last month of the year and on credit terms. Usually the credit period is short, approximately a few days.

ASSESSMENT OF COLLECTABILITY:

●

Recording of Accounts Receivable: All amounts due on physical delivery of the merchandise from the drop shipper, must be promptly recorded as an accounts receivable. Each account receivable must be recorded and maintained until payment is received or the recorded amount is written off or extinguished.

●

An adequate provision for doubtful accounts must be established. When all reasonable efforts fail to collect an account receivable and it has been approved for write off, the related provision for doubtful accounts should be reduced.

●

Statements to Debtors: Statements must be issued to debtors, on a monthly basis, providing meaningful and concise information on the status of their debts.

●

Accounts receivable are considered overdue when a debtor does not pay or resolve the debt within 30 days from the invoice date or a written request for payment to the debtor.

●

All actions taken to collect overdue accounts must be documented.

●

If there is no response after the initial contact at the 30-day point (within 30-day period 60 days from date of invoice),to the Company will take prompt and vigorous action to collect overdue accounts receivable.

●

Accounts receivable, in most cases, should be at least 30 days overdue (i.e., 60 days after invoice notification), before staff advises debtors that their accounts are overdue and that the accounts may be:

o

turned over to a private collection agency;

o

subject to legal action;

o

credit privileges will be revoked; and/or account may be suspended.

Most Recent accounting pronouncements

Refer to Note 2 in the accompanying unaudited condensed financial statements.

Impact of Most Recent Accounting Pronouncements

There were no recent accounting pronouncements that have had a material effect on the Company's financial position or results of operations.

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company's financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not applicable.

Item 4. Controls and Procedures.

Management does not expect that its internal controls over financial reporting will prevent all errors and all fraud. Control systems, no matter how well-conceived and managed, can provide only reasonable assurance that the objectives of the control system are met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include those judgments in decision-making can be faulty and that breakdowns can occur because of simple errors or mistakes.

Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of management, including the principal executive officer and principal financial officer, as of September 30, 2024, The Company conducted an evaluation of its disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended. Based on this evaluation, the principal executive officer and principal financial officer have concluded that, based on the material weaknesses discussed below, the disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act were recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Act Commission's rules and forms and that its disclosure controls are not effectively designed to ensure that information required to be disclosed in the reports that the Company files or submits under the Securities Exchange Act is accumulated and communicated to management, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

The Company's internal controls are not effective for the following reasons, (1) there are no entity level controls, because of the limited time and abilities of the Company's three officers, (2) there is no separate audit committee, and (3) the Company has not implemented adequate system and manual controls. As a result, the Company's internal controls have inherent weaknesses, which may increase the risks of errors in financial reporting under current operations and accordingly are not effective as evaluated against the criteria set forth in the Internal Control - Integrated Framework issued by the committee of Sponsoring Organizations of the Treadway Commission (1992 version). Based on the evaluation, management concluded that the Company's internal controls over financial reporting were not effective as of September 30, 2024.

Even though there are inherent weaknesses, management has taken steps to minimize the risk. The Company uses a third-party consultant to review transactions for appropriate technical accounting, reconcile accounts, review significant transactions, and prepare financial statements. Any deviation or errors are reported to management.

The Company can provide no assurance that its internal controls over financial reporting will be compliant in the near future. As revenues permit, the Company will enhance its internal controls through additional software and other means. If and when it becomes a listed company under SEC rules, the Company intends to create an audit committee comprised of independent directors.

Changes in Internal Control over Financial Reporting

There have been no changes in the Company's internal control over financial reporting during the last quarterly period covered by this report that have materially affected, or are reasonably likely to affect, the internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

We are not currently involved in any litigation nor to our knowledge, is any litigation threatened against us, the outcome of which would, in our judgment based on information currently available to us, have a material adverse effect on our financial position or results of operations. However, two parties have filed an action against the Company for breach of contract for failure to make payment on promissory notes, that were entered into when the Company purchased the Myakka farm. The Court has entered judgment against the Company for these promissory notes. The Company is working to resolve these matters, and do not expect that the cases will have a material adverse effect on our financial position or results of operations.

Item 1A. Risk Factors.

Not applicable.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None

Item 3. Defaults Upon Senior Securities.

None

Item 4. Mine Safety Disclosures.

Not Applicable

Item 5. Other Information.

None

Item 6. Exhibits.

(a) Exhibits required by Item 601 of Regulation S-K.

Exhibit		Description
3.1		Articles of Incorporation*
3.2		Articles of Conversion*
3.3		Bylaws*
31.1		Certification of the Company's Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant's Report on Form 10-Q for the quarter ended September 30, 2024.**
31.2		Certification of the Company's Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant's Report on Form 10-Q for the quarter ended September 30, 2024.**
32.1		Certification of the Company's Principal Executive Officers pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.***
101.INS		Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document**
101.SCH		Inline XBRL Taxonomy Extension Schema Document**
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document**
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document**
101.LAB		Inline XBRL Taxonomy Extension Labels Linkbase Document**
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document**
104		Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit)**

* Incorporated by reference to the Company's Registration Statement on Form S-1 filed with the Commission on February 9, 2022.

** Filed Herewith

*** Furnished, not filed, in accordance with item 601(32)(ii) of Regulation S-K.

SIGNATURES

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	PIONEER GREEN FARMS, INC.
Dated: November 19, 2024	By:	/s/ Michael Donaghy
	Name:	Michael Donaghy
	Title:	Chief Executive Officer
		(Principal Executive Officer)

Dated: November 19, 2024	By:	/s/ Michael Donaghy
	Name:	Michael Donaghy
	Title:	Interim Chief Financial Officer
		(Principal Financial and Accounting Officer)